Partners

GEROPHARM is an international producer of biotechnology products specializing in neurology, endocrinology, ophthalmology, gynecology, and urology. Its’ portfolio includes 40 original medicines and generics. GEROPHARM tops the Russian insulin market and is among the top 10 insulin manufacturers in the world. The Company runs all production stages at its own facilities in Russia by GxP standards. In 2023 GEROPHARM registered Semavic®, Russia's first Ozempic® analog, and in 2025 presented Mounjaro analog – Sejaro®. Medicinal products of the Company are represented in 14 countries.

SIBUR is one of the fastest growing companies in the global petrochemical industry.

We produce in-demand products for society and use advanced technologies to create new opportunities, invest in social infrastructure and improve the quality of people’s lives. We evolve through partnership and sharing of experience, continuous growth, pursuit of ambitious goals and commitment to sustainability.

SIBUR's polymer solutions are successfully used in the production of medical devices, pharmaceuticals and pharmaceutical packaging, hygiene products.

Limited liability company «Capital Medical Insurance» (LLC «Capital MI») is one of the leading medical insurance companies in the field of state healthcare system of Russian Federation. The company is part of the Sovcombank group since 2026. Number of insured persons – 22 million people. Our organization has 660 representative offices in 41 federal subjects. 4800 medical organizations are involved in provision of medical care for our insured persons. 5000 employees are working on providing availability of medical care. Company’s mission is to promote the priority of healthcare in the system of social values of society and to provide availability of free high-quality medical services everywhere. LLC «Capital MI» is at the spearhead of interdepartmental interaction with the goal of solving social security and healthcare problems. Company developments received high praise and were recommended for replication numerous times on the regional and federal levels of healthcare system.

Our goal is to create a national ecosystem for predicting and correcting neuropsychiatric disorders even before birth. Currently, we are supporting research into studying specific fetal brain proteins in the mother’s blood, which makes it possible to understand why and how delays in the child’s brain development and other pathologies occur at different stages of pregnancy, and will enable the future identification of “defects” that lead to neuropsychiatric disorders in children (autism, ADHD, etc.).

Our mission: «Children’s health — the health of future generations through prenatal brain research».

Areas of work:

1. Supporting scientific research into the development of a child’s brain in utero, in partnership with the Federal State Budgetary Institution “National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V. I. Kulakov”;

2. Promoting science: the popular science portal “Alice in the World of Science” alisacharity.com;

3. Supporting young scientists.

Chromolab is a research and diagnostic laboratory that has been advancing clinical metabolomic diagnostics in Russia for over 22 years.

We believe that clinical metabolomics is a cornerstone of modern personalized medicine.

We specialize in high-precision laboratory testing using chromatography–mass spectrometry, drawing on advanced technologies and scientific advances.

Chromolab brings together science, innovation, exceptional service, and a commitment to patient health.

We help physicians gain a deeper understanding of their patients’ health by providing resources to support the interpretation of test results, developing educational materials, and offering consultations, training, and hands-on workshops.

Our mission is to help prevent disease by making preventive diagnostic testing and personalized medicine more accessible.

We are passionate about our work and welcome new ideas and opportunities for collaboration.